Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.
S. FDA) for Azelaic Acid Gel, 15%, a generic version of Finacea1 Gel, 15%, of Leo Pharma A/S.
According to IQVIA sales data for the 12 month period ending September 2018, the Finacea Gel, 15% market2 achieved annual sales of approximately $64.1 million.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)